Document is current
Any future updates will be listed below
-
Authors
Born, Tristan
Perreau, Matthieu
Axisa, Pierre-Paul
Fenwick, Craig
Pinto, Andrea
Ben-Hamouda, Nawfel
Rossetti, Andrea O.
Du Pasquier, Renaud
Chiche, Jean-Daniel
Bernard-Valnet, Raphaël https://orcid.org/0000-0001-7447-344X
-
Funding
Funding for this research was provided by:
University of Lausanne
- License Information
-
More Information
Article History
Received: 12 August 2025
Accepted: 5 November 2025
First Online: 12 November 2025
Declarations
:
: This study was approved by the local Ethics Committee (CER-VD) under the CORO-NEURO study (authorization n o . 2020-01123). Informed consent was obtained from all living participants; however, it was waived for those who had passed away.
: Not applicable.
: TB holds shares in Pfizer Inc. (PFE) and Novartis AG (NOVN). MP has nothing to disclose. CF has nothing to disclose. NBH has nothing to disclose. AOR has nothing to disclose. RDP has nothing to disclose. JDC has nothing to disclose. RBV has received travel and speaking/advisory board honoraria from Merck, Roche, Juvisé, Sanofi and Novartis, and research support from the Novartis Foundation, all unrelated to the current work.
